Ciclopirox topical - Ortho Dermatologics

Drug Profile

Ciclopirox topical - Ortho Dermatologics

Alternative Names: 12% Ciclopirox lacquer - Ortho Dermatologics; 8% Ciclopirox lacquer - Ortho Dermatologics; Ciclopirox nail lacquer - Ortho Dermatologics; DL 6045; Penlac; Penlac Nail Lacquer

Latest Information Update: 02 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dermik Laboratories
  • Developer Ortho Dermatologics
  • Class Antifungals; Pyridones; Small molecules
  • Mechanism of Action Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Onychomycosis

Most Recent Events

  • 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
  • 15 Dec 2016 Biomarkers information updated
  • 16 Dec 2011 Dermik Laboratories has been acquired by Valeant Pharmaceuticals International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top